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IL-10 was originally described as a cytokine produced by
Th2 cells and mediating antiinflammatory effects, by acting
primarily on phagocytic cells and on antigen-presenting
cells (1). IL-10 inhibits, in these cells, transcription and
production of proinflammatory cytokines, such as TNF
and IL-12, expression of MHC class II, and costimulatory
molecules, as well as the production of reactive oxygen and
nitrogen intermediates (1). In part through inhibition of
IL-12 production and of costimulatory molecule expres-
sion on antigen-presenting cells, IL-10 has an overall sup-
pressive effect on the generation of Th1 responses. In addi-
tion, IL-10 profoundly affects the bactericidal activity of
phagocytic cells, allowing intracellular survival of patho-
gens such as 
 
Mycobacterium tuberculosis
 
 (2) and 
 
Leishmania
major
 
 (3). In addition to inhibit the intracellular bactericidal
mechanisms, IL-10 was shown to prevent TNF-mediated
apoptosis of 
 
M. tuberculosis
 
 infected macrophages thus possi-
bly facilitating the maintenance of a chronic infection (4).
Many experimental and clinical studies have shown that
the in vivo production of IL-10 during intracellular patho-
gen infections represents a regulatory mechanism to pre-
vent pathogenic systemic inflammatory responses. Even in
the presence of IL-10, the protective effect of a regulated
Th1 response is largely preserved, although in some in-
stances sterile cure in chronic infection by intracellular par-
asites may be prevented. Several studies also indicate that
the principal source of IL-10 may be T cells that also pro-
duce IFN-
 
 
 
, in addition or instead of Th2 cells or cells in-
fected or exposed to parasite products, e.g., macrophages,
which may be the predominant producer of IL-10 during
the early acute phases of the infection.
 
IL-10 Is Essential to Protect Infected Animals from Severe In-
flammatory Pathology.
 
The central and necessary role of
IL-10 in protecting against severe or systemic inflammatory
pathology has been clearly shown in many models of ex-
perimental infection with intracellular pathogens using IL-
10 genetically deficient (IL-10
 
 
 
/
 
 
 
) mice. In these animals,
the ability to resist infection to pathogens such as 
 
L. major
 
,
 
M. tuberculosis
 
, 
 
Listeria monocytogenes
 
, or 
 
Toxoplasma gondii
 
 is
enhanced or unaffected (3, 5). However, severe pathogenic
inflammatory responses upon infection are often observed
in these animals. IL-10
 
 
 
/
 
 
 
 mice exhibited lethal hyperin-
flammatory intracerebral immune response in 
 
L. monocy-
togenes
 
 meningoencephalitis, while, if infected intraperito-
neally, they exhibited hepatic hyperinflammation (6).
Female IL-10
 
 
 
/
 
 
 
 mice infected with 
 
Plasmodium chabaudi
chabaudi
 
 have an exacerbated pathology including hypogly-
cemia, hypothermia, and loss in body weight often result-
ing in death (7). IL-10
 
 
 
/
 
 
 
 mice infected with 
 
T. gondii
 
, al-
though able to resist the infection, succumb within 1 or 2
wk to a systemic inflammatory response with enhanced
production of IL-12, IFN-
 
 
 
, and TNF (8).
 
In Experimental L. major Chronic Infection, IL-10 Produced
by T Cells Prevents Sterile Cure. L. major
 
 infection in mice
represents a powerful model to study the role of Th1 and
Th2 responses in the resistance to intracellular pathogens.
Whereas most mouse strains are able to mount a Th1 re-
sponse to 
 
L. major
 
 and resist the infection, at least one
strain, BALB/c, exhibits a Th2 response and it is unable to
resist the infection that eventually becomes generalized and
lethal. However, IL-10
 
 
 
/
 
 
 
 BALB/c mice were relatively
resistant to infection, indicating that endogenous IL-10
plays an important role in allowing disease progression in
IL-10 sufficient mice (3). Interestingly, in this model, one
of the mechanisms of IL-10 induction was the triggering of
Fc receptor on macrophages by IgG antibody coated 
 
L.
major
 
 amastigotes (9, 10). Although 
 
L. major–
 
resistant
mouse strains mount a protective Th1 response to the in-
fection, sterile cure is not obtained even many weeks after
infection and a small number of parasites persists at the site
of infection and in the draining lymph node, possibly
within dendritic cells (DCs) and fibroblasts, rather than in
typical phagocytic cells (11–13). Immune pressure during
this latency is mediated by Th1 cells, IL-12, IFN-
 
 
 
, and in-
ducible nitric oxide synthase (iNOS); blockage of these
mechanisms induces parasite reactivation and reappearance
of the lesions, reminding the clinical occurrence of latent
infections and the severe forms of reactivation diseases in
human leishmaniasis. In this issue, Belkaid et al. (14) show
that IL-10 plays an essential role in 
 
L. major
 
 persistence in
genetically resistant C57BL/6 mice after spontaneous heal-
ing of their dermal lesions. They demonstrate that sterile
cure was achieved in IL-10
 
 
 
/
 
 
 
 mice but not in IL-10 suffi-
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cient mice. This requirement for IL-10 in establishing la-
tency was determined in mice infected either by intrader-
mal injection of 
 
L. major
 
 metacyclic promastigotes and by
the natural route by exposure of the skin to infected sand
flies. Most importantly, IL-10 sufficient C57BL/6 mice
treated transiently (2 wk) during the chronic phase with
anti–IL-10 receptor antibodies achieved sterile cure, sug-
gesting that IL-10 was actively involved in preventing
complete parasite elimination even in the presence of a
Th1 response (14). After 1 wk treatment with the anti–IL-
10 receptor antibody, the number of CD4
 
 
 
 and CD8
 
 
 
 T
cells recovered from the chronic phase lesions was dramati-
cally reduced (14). This might be explained by the disap-
pearance of the antigenic stimulus provided by the parasites
or alternatively by the ability of IL-10 to prevent complete
resolution of the infiltration by inhibiting production of
TNF that induces T cell apoptosis or by directly protecting
T cells from apoptosis (4, 15, 16). Thus, IL-10 produced in
the lesion during the latent infection may control various
parameters of the host parasite relationship, including the
survival and persistence of the infiltrating T cells and their
ability to induce bactericidal activity in the cells harboring
the parasites.
The CD4
 
 
 
 and, in part, the CD8
 
 
 
 T cells infiltrating the
dermal chronic lesion maintained high levels of IFN-
 
 
 
 pro-
duction until the latent infection persisted (14). IL-10 also
derived from T cells and prevalently from CD4
 
 
 
 T cells:
the majority of the CD4
 
 
 
 T cell producing IL-10 (7% of
total CD4
 
 
 
 T cells) also produced IFN-
 
 
 
: these double IL-
10 and IFN-
 
 
 
 producing cells represented approximately
one quarter of all the IFN-
 
 
 
–producing cells. Thus, the IL-
10 responsible of the immunoregulation of the anti-
 
Leish-
mania
 
 response in this resistant strain of mice was produced
primarily by a subset of IFN-
 
 
 
 producing CD4 cells, rather
than by Th2 cells or by the infected phagocytic cells.
 
CD4
 
 
 
 T Cells Producing both IFN-
 
 
 
 and IL-10 Are Present
in Human Clinical Infections.
 
The ability of CD4
 
 
 
 T cell to
produce both IFN-
 
 
 
 and IL-10 clearly shows that the pro-
duction of IL-10 from T cells is not always associated with
a Th2 response, but could be observed from T cells partici-
pating to a Th1–type response (17, 18). Before their identi-
fication in 
 
L. major
 
 infection (14), T cells producing both
IFN-
 
 
 
 and IL-10 had not been directly shown in any ex-
perimental model of chronic infection, but in humans there
are many examples of an immune regulatory balance be-
tween IFN-
 
 
 
 and IL-10 in persistent infection as well as di-
rect evidence of simultaneous production of both cytokines
from T cells.
It is of interest that all human CD4
 
 
 
 T cell clones ex-
panded in vitro in the presence of the Th1 inducing cyto-
kine IL-12 produced high levels of both IFN-
 
 
 
 and IL-10
(19). If the clones were expanded in the presence of both
IL-12 and IL-4, their ability to produce IL-10 was com-
pletely suppressed, whereas the production of IFN-
 
 
 
 was
minimally affected (19). Thus, the ability of CD4
 
 
 
 T cells
to produce IL-10 is positively regulated by IL-12 and nega-
tively by IL-4, suggesting that the balance between IL-12
and IL-4 during an infection may regulate not only the di-
chotomy between Th1 and Th2 responses, but also the
type of Th1 responses and their association with the anti-
inflammatory cytokine IL-10.
In human tuberculosis, increased expression of both
IFN-
 
 
 
 and IL-10, but not of typical Th2 cytokines (e.g.,
IL-4) was observed in lymph nodes and at the sites of infec-
tion, although the production of IL-10 from T cells was
not directly demonstrated (20). However, within CD4
 
 
 
clones derived from bronchoalveolar lavage (BAL) of active
pulmonary tuberculosis patients, clones producing high
levels of both IFN-
 
 
 
 and IL-10 predominated and repre-
sented approximately half of the clones, whereas their pro-
portion was significantly lower in clones derived from BAL
of healthy controls (19). This pattern was not observed in
CD4
 
 
 
 clones derived from peripheral blood in which IL-
10 production was observed predominantly in typical Th2
clones producing also IL-4 (19). The simultaneous produc-
tion of IFN-
 
 
 
 and IL-10 was observed both in 
 
M. tuberculo-
sis
 
 specific and nonantigen specific clones. This observation
suggests that the IFN-
 
 
 
 and IL-10 producing clones may
be preferentially enriched at the site of infection and/or
specific anatomical localization such as the lungs. Because
these clones were isolated from patients with active pulmo-
nary tuberculosis, it is possible that the production of IL-10
was responsible for the inability of the patients to clear the
infection, or that IL-10 had a protective role in preventing
a more severe inflammatory pathology in the patients’ in-
fected tissues. The possible role of IL-10 producing T cells
in suppressing the immune response of pulmonary tubercu-
losis patients was suggested by the observation that T cells
from anergic patients that lacked dermal reaction to tuber-
culin produced IL-10 but not IFN-
 
 
 
 both constitutively
and upon stimulation, were defective in T cell receptor–
induced signal transduction, and inhibited allogeneic mixed
leukocyte reactions (21).
Production of high levels of both IFN-
 
 
 
 and IL-10 was
observed in a high proportion of 
 
Borrelia burgdorferi
 
–specific
T cell lines isolated from patients with Lyme disease, but
not in tetanus toxoid positive lines from patients or in 
 
B.
burgdorferi
 
–reactive lines from healthy controls (22). Neu-
tralization of IL-12 inhibited the generation of the double
producing T cell lines, indicating the role of IL-12 in in-
ducing IFN-
 
 
 
 and IL-10 producing T cells (22). In mice,
early production of IFN-
 
 
 
 and IL-10 upon infection with
 
B. burgdorferi
 
 was observed. However, in strains susceptible
to Lyme disease, IFN-
 
 
 
 production was higher and less
controlled by IL-10 than in resistant strains, suggesting that
IL-10 production and sensitivity to the regulation by IL-10
of IFN-
 
 
 
 production during 
 
B. burgdorferi
 
 infection may
determine the susceptibility to Lyme arthritis (23).
In malaria there is a complex relationship between the
roles played by both innate and adaptive inflammatory re-
sponses in the protection against parasite proliferation and
in the induction of the most acute and life threatening
manifestations of the disease (24). In particular, both TGF-
 
 
 
and IL-10 have been shown to mediate important antiin-
flammatory mechanisms in malaria, with TGF-
 
 
 
 being able
to induce IL-10 production without decreasing IFN-
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production (25). High IL-10 to TNF ratios were observed
in 
 
P. falciparum
 
 infected patients from endemic areas with
uncomplicated malaria or hyperparasitemia, whereas low
IL-10 to TNF ratios were associated with anemia and cere-
bral malaria complications (26, 27). In patients with acute
uncomplicated 
 
P. falciparum
 
 malaria, a significant number of
peripheral blood CD4
 
 
 
 T cells producing both IFN-
 
 
 
 and
IL-10 was indeed observed and their number increased
during drug-induced clearance of parasitemia (28).
 
The IFN-
 
 
 
/IL-10 Double-producing CD4
 
 
 
 T Cells in In-
fection May Correspond to T Regulatory Cell Subsets.
 
The
stimuli by which IL-10 and IFN-
 
 
 
 double-producing T
cells are induced and the exact mechanism by which they
regulate the anti-parasite response while preventing hyper-
inflammation remain largely unknown. However, some
leads for the understanding of the regulation and activity of
these cells have been provided by the recent flow of infor-
mation regarding T regulatory cells in autoimmunity,
transplantation, and cancer. Particularly relevant are the
Tr1 cells that are generated by stimulation in the presence
of IL-10 and produce high level of IL-10 associated with
intermediate level of IFN-
 
 
 
 as well as the CD4
 
 
 
CD25
 
 
 
 Tr
cells recently characterized both in mouse and in humans
(29, 30). Although IL-10 production and often TGF-
 
 
 
production were reported to be general characteristics of T
regulatory cells, the ability of these cells to suppress im-
mune responses in vivo or in vitro has been shown to be
mediated at least in part by IL-10 in some experimental sys-
tem but not in others (29–31). In particular, the human
CD4
 
 
 
CD25
 
 
 
 peripheral blood T cell subset identified re-
cently in several studies was shown to produce IL-10 but to
exert immunosuppressive activity via a cell contact-depen-
dent IL-10–independent mechanism (31).
Both in the mouse and in humans IL-10 and TGF-
 
 
 
have been shown to be important for activation/differenti-
ation of Tr cells (28–30). These two cytokines, produced
early in the infection by phagocytes or other cells infected
or exposed to parasite products, could activate T cell sub-
sets producing them (e.g., the IL-10 and IFN-
 
 
 
 producing
T cells). These T cells could then persist at the site of infec-
tion modulating the inflammatory response. Studies in pa-
tients with Lyme disease, as mentioned above, suggests that
also IL-12 may be an important cytokine responsible for
the differentiation of the IL-10 and IFN-
 
 
 
 producing T
cells in human chronic intracellular infections (22).
In the mouse, CD4
 
 
 
CD25
 
 
 
 Tr cells have been shown
to be generated in the thymus after high affinity TCR in-
teraction with self-peptide through a process distinct from
positive selection and deletion (32). However, whether
they can also derive in the periphery from naive T cells or
are simply expanded or activated from thymus-derived cells
already primed for regulatory functions remains an open
question (29). Although both autoimmunity and transplan-
tation studies suggest the possibility that Tr may differenti-
ate from naive T cells (29), the fact that in infectious dis-
eases IFN-
 
 
 
 and IL-10 producing T cells are often
observed in both parasite-specific and nonspecific T cell
clones may argue in favor of activation of nonspecific by-
stander T cells or of T cells cross-reactive with self-anti-
gens. These T cells may regulate the specific immune and
inflammatory responses in a nonantigen specific way by
producing antiinflammatory cytokines such as IL-10 and
TGF-
 
 
 
 or by other mechanisms. An example of possible
activation by pathogens of Tr cells cross-reactive with self-
antigens is provided by the induction of immunosuppres-
sive IL-10–producing T cells by a mycobacterial hsp70
sequence cross-reacting with the mammalian hsp-70 ho-
mologue (33). Stimulation of 
 
P. falciparum
 
 specific clones
by the specific peptide in the presence of certain naturally
occurring altered peptide ligands was also shown to alter
the functional characteristics of established antigen-specific
clones from effector Th1 type cells producing high levels of
IFN-
 
 
 
 to immunosuppressive cells producing IL-10 and
lower level of IFN-
 
 
 
 (34). It was proposed that this mech-
anism could be responsible for the low level of T cell re-
sponses observed in endemic malaria areas in which coin-
fection with several 
 
P. falciparum
 
 variants is frequent (34).
Chronic exposure to superantigen in mice, possibly
mimicking what happens in persistent infection, induces
regulatory T cell with IL-10 mediated suppressive activity
(35). Both in vivo and in vitro it has been shown that im-
mature DCs may induce the differentiation of Tr (30) sug-
gesting that intracellular pathogens such as 
 
L. major
 
 could
induce Tr cells because of their ability to infect DCs and to
modulate the activation and cytokine production of anti-
gen presenting cells (13, 36). Alternatively, it is possible
that different subsets of DCs might be responsible for dif-
ferentiation of functional subsets of T cells (30). The IFN-
 
 
 
producing human plasmacytoid DCs, when infected by
viruses, have been shown to induce the differentiation of T
cells producing both IL-10 and IFN-
 
 
 
 (37, 38). This effect
was mediated by IFN-
 
 
 
 and probably IL-12. IFN-
 
 
 
 in co-
operation with IL-10 has indeed been shown to induce hu-
man Tr cells that produce both IFN-
 
 
 
 and IL-10 (39). The
production of IFN-
 
 
 
/
 
 
 
 and the possible role of plasmacy-
toid DCs in intracellular infections by pathogens other than
viruses has been poorly investigated. However, IFN-
 
 
 
/ 
was shown to be induced early after infection of mice with
L. major and to be required for iNOS activation (40) and
virulence of a M. tuberculosis clinical isolated was demon-
strated to be associated with its ability to induce IFN- / 
production (41).
Conclusions. From the many experimental and clinical
studies discussed above a clear picture is emerging that IL-
10 is involved in limiting inflammation although often also
in preventing sterile cure in chronic infection by intracellu-
lar parasites. The principal source of IL-10 in persistent in-
fection may be T cells that also produce IFN- , in addition
or instead of Th2 cells or cells infected or exposed to para-
site products, e.g., macrophages. However, the observation
in various clinical studies of the presence of T cells produc-
ing both IFN-  and IL-10 was almost anedoctical and of
unclear physiological significance. The demonstration by
Belkaid et al. (14) in this issue of the presence of these cells
in L. major infected mice and of their role in preventing a
sterile cure of the infected animals indicates that these cellsF56 Commentary
play an important role in modulating the immune response
against intracellular parasites and provides an experimental
model for their study. The understanding of the specificity
of these cells, their mechanisms of activation and persistence
as well as the cytokines and the antigen presenting cells in-
volved in their generation and function will undoubtedly
teach us much about the regulation of the host-parasite rela-
tionship, especially in chronic persistent infection.
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